INTEGRATED BIOPHARMA INC Increase Decrease In Operating Lease Liability
INTEGRATED BIOPHARMA INC (INBP) reported Increase Decrease In Operating Lease Liability of -$756.00 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-05-08
- INTEGRATED BIOPHARMA INC increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$267.00K.
- INTEGRATED BIOPHARMA INC increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$246.00K.
- INTEGRATED BIOPHARMA INC increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$243.00K.
- INTEGRATED BIOPHARMA INC increase decrease in operating lease liability for the quarter ending 2025-03-31 was -$228.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month |
|---|---|---|---|
| 2026-03-31 | -$267.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | -$513.00K derived: sum of 2 quarters · filed 2026-05-08 | -$756.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | -$246.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-11 | -$489.00K 10-Q · filed 2026-02-11 | |
| 2025-09-30 | -$243.00K 10-Q · filed 2025-11-10 | ||
| 2025-03-31 | -$228.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-08 | -$464.00K derived: sum of 2 quarters · filed 2026-05-08 | -$696.00K 10-Q · filed 2026-05-08 |
| 2024-12-31 | -$236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-11 | -$468.00K 10-Q · filed 2026-02-11 | |
| 2024-09-30 | -$232.00K 10-Q · filed 2025-11-10 | ||
| 2024-03-31 | -$226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | -$451.00K derived: sum of 2 quarters · filed 2025-05-14 | -$672.00K 10-Q · filed 2025-05-14 |
| 2023-12-31 | -$225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$446.00K 10-Q · filed 2025-02-13 | |
| 2023-09-30 | -$221.00K 10-Q · filed 2024-11-13 |